Pharmacy and materia medica

Pharmaceutical Fronts

Georg Thieme Verlag KG · Germany · ISSN 2628-5096
No APC DOI Verified OA Visit journal
Articles
205

Pharmaceutical Fronts is a peer-reviewed english-language open-access journal published by Georg Thieme Verlag KG in Germany, operating under an open-access model since 2019. The journal covers Pharmacy and materia medica.

Authors publish in Pharmaceutical Fronts without paying any article processing charge (APC) — making it a fully diamond/platinum open-access venue, supported entirely by its publisher or sponsor. Articles are released under the CC BY license (see other journals using this license).

To date, Pharmaceutical Fronts has published 205 articles. Articles are minted with DOIs through the prefix 10.1055.

Keywords

pharmacology, pharmaceutical chemistry, medical chemistry, organic chemistry, pharmacy

At a glance

Country
Germany
Primary language
English
License
CC BY
Peer review
Double anonymous peer review
OA since
2019
DOI prefix
10.1055

ISSN

print
2628-5088
electronic
2628-5096

Frequently asked questions

Is Pharmaceutical Fronts peer-reviewed?
Yes — Pharmaceutical Fronts operates a Double anonymous peer review review process.
Does Pharmaceutical Fronts charge an article processing charge (APC)?
No. Pharmaceutical Fronts does not charge any APC. Publication is free for accepted authors.
What subjects does Pharmaceutical Fronts publish?
Pharmaceutical Fronts publishes research in Pharmacy and materia medica.
What languages does Pharmaceutical Fronts accept?
Pharmaceutical Fronts accepts manuscripts in English.
What is the ISSN of Pharmaceutical Fronts?
ISSN: 2628-5088 (print) · 2628-5096 (electronic).
How do I submit a manuscript to Pharmaceutical Fronts?
Submit through the journal's official portal: visit submission page →

Similar journals

Other open-access journals in Pharmacy and materia medica.

Help us grow the directory

Know an open-access journal we don't list yet?

Add it in under a minute. Each suggestion is reviewed by a human editor.

WhatsApp